Sahin, Aysegul A.
The University of Texas MD Anderson Cancer Center,
United States
2024 Rank: 158,647
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 5,197 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 158,647 | 176,109 |
| Total Cites | 1,804 | 1,883 |
| H-index | 19 | 19 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 13 | 14 |
| Number of Single+First+Last Authored Papers | 82 | 82 |
| Total Cites to Single+First+Last Authored Papers | 89 | 92 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,576 | 1,626 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
4.20%
|
|
Sahin, Aysegul A.
The University of Texas MD Anderson Cancer Center,
United States
2023 Rank: 152,805
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 5,435 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152,805 | 178,284 |
| Total Cites | 2,073 | 2,178 |
| H-index | 22 | 22 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 18 | 18 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 85 | 86 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,788 | 1,851 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.18 |
| Self-Citation Percentage |
4.82%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,878 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129,516 | 147,245 |
| Total Cites | 2,138 | 2,235 |
| H-index | 21 | 22 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 22 | 22 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 109 | 109 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1,883 | 1,956 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.14 |
| Self-Citation Percentage |
4.34%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 4,433 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124,135 | 142,267 |
| Total Cites | 3,165 | 3,331 |
| H-index | 28 | 28 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 31 | 32 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 161 | 163 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2,763 | 2,876 |
| Ratio of Total Citations to Distinct Citing Papers | 1.15 | 1.16 |
| Self-Citation Percentage |
4.98%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.